Genpharm is very proud to be awarded the Best Pharmaceutical Market Access company for 2017 for the UAE and the MENA region

Dubai, February 22nd 2018

“This can only be achieved with the full commitment of our staff to our vision and values”,  says Karim Smaira Managing Partner Genpharm. “It makes all the hard-work worthwhile particularly because this means that rare disease patients are getting access to the needed therapies through our efforts”.

“After being awarded the 2016 best regional pharmaceutical company, this is another milestone on our journey to excellence. We aspire to set new standards in our industry and I believe this award is a testimony that we are on the right track. Patients and physicians are thankful for getting access to orphan drugs and this is the biggest reward. I would like to thank our staff for believing in our core mission and pursuing with passion this objective” Kamel Ghammachi, Managing Partner .

Genpharm is a regional pharmaceutical market access company, focused on rare and genetic disease. It provides fast and sustainable market access solutions for innovative pharmaceutical and Biotech companies aiming at expanding their presence in the MENA region.

For more information please visit